HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Chlorodiazepam

HCID 76168
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
2894-68-0
Standard SMILES
CN1C(=O)CN=C(c2ccccc2Cl)c2cc(Cl)ccc21
InChIKey
VPAYQWRBBOGGPY-UHFFFAOYSA-N
Molecular formula
C16H12Cl2N2O
Average molar mass
319.2 g/mol
Monoisotopic mass
318.0326684

Overview

Diclazepam is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Depressants substance.

Names & identifiers

Preferred name
Chlorodiazepam
IUPAC
7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
English name
Diclazepam
Molecular formula
C16H12Cl2N2O
Molecular weight
319.19

Names & synonyms

2-Chlorodiazepam2894-68-0Chlorodiazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-070818R7PBDEA NO. 2789DTXSID301831387-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-oneRefChem:470412DTXCID40105629Diclazepam2'-Chlorodiazepam
Show more names
etizolam powderDiclazepam (CRM)diclazepam powderDiclazepam, Ro5-3448Diclazepam USP/EP/BP2-chlorodiazepam /Diclazepam
7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-oneRo 5-3448o-ChlorodiazepamUNII-070818R7PBHSDB 6959CHEMBL268248SCHEMBL7486030

Database identifiers

CAS
2894-68-0
PubChem CID
76168
DTXSID
DTXSID30183138

Properties

Computed structural propertiesFilling in

XLogP
3.1
Topological polar surface area
32.7 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
21
Formal charge
0
Complexity
440

Experimental & physicochemical properties

Drugs · 3 items

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule I Controlled Substance -> Depressants

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP · 2 items

log Kow = 3.12

3.12

Physicochemical properties

Melting point
217 · 217-219℃ (dichloromethane ethyl ether )
Boiling point
524.6 · 524.6±50.0 °C(Predicted)
Density
1.35 · 1.35±0.1 g/cm3 (20 ºC 760 Torr)
solubility
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml
form
A neat solid
pka
1.75 · 1.75±0.25(Predicted)
FDA UNII
70818 R7PB · 070818R7PB
Symbol(GHS)
7 · GHS07
Signal word

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301+H311 (100%): Toxic if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]

P262, P264, P270, P273, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P391, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Regulatory InformationDEA schedule I controlled substance
FDA Requirements · 1 item

Schedules of controlled substances are established by section 202 of the Controlled Substances Act (21 U.S.C. 812). Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of uscch salts, isomers, and salts of isomers is possible within the specific chemical designation. Schedule IV includes diazepam, DEA Code #2765; Drug class: Depressants.

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxicology

Chemistry & industry

Applications · 2 items

DescriptionDiclazepam, also known as 2-chlorodiazepam and chlorodiazepam, is classed in the benzodiazepam family, and is therefore a diazepam analogue.It was first synthesized by Leo Sternbach and his team at Hoffman-La Roche in 1960, but it was not pursued as a pharmaceutical product.Diclazepam dosage, efficacy or safety in humans has never been formally studied. In animals, however, it is known to have very similar effects to flubromazepam and diazepam itself. Its effects include working as an anticonvulsant and anxiolytic, a sedative, a hypnotic, an amnesiac and as a skeletal muscle relaxant. It may have adverse effects such as drowsiness, and cognitive impairments such as short term memory impairment. Diclazepam has been assessed as having an elimination half-life of around 42 hours in most animals. In the body, it undergoes N-demethylation, resulting in the creation of delorazepam. The delorazepam can be detected in the subject’s urine for approximately six days. It also metabolises into lormetazepam (detectable for 19 days) and lorazepam (detectable for 11 days). This suggests that cytochrome P450 enzymes are also engaging in hydroxylation of the compound at the same time as the N-demethylation.

UsesChlorodiazepam-13C,d3, is the labeled analogue of Chlorodiazepam (C366830), which is a 4'-chloro derivative of diazepam (D416855), having analgesic, and possible antidepressant cardioprotective and anti-cancer effects.

Related reactions

1 records
New reaction record
HRID 1076388 reaction equation
HRID 1076388As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL268248
UNII
070818R7PB
EC Number
111-026-8
Nikkaji
J47.042B
Warning
Hazard statements
302 · H302
Precautionary statements
264 · P264-P270-P301+P312-P330-P501
Risk Statements
22 · 22
Safety Statements
22 · 22-24/25
Hazardous Substances Data
2894 · 2894-68-0(Hazardous Substances Data)
Antidote and Emergency Treatment · 2 items

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam (Valium) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poison A and B/

Regulatory information

FDA Requirements · 1 item

Schedules of controlled substances are established by section 202 of the Controlled Substances Act (21 U.S.C. 812). Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of uscch salts, isomers, and salts of isomers is possible within the specific chemical designation. Schedule IV includes diazepam, DEA Code #2765; Drug class: Depressants.

Safety data

risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
22-24/25
Hazard statements
H302
Precautionary statements
P264-P270-P301+P312-P330-P501
Hazardous Substances Data
2894-68-0(Hazardous Substances Data)